Accelerating Compound Discovery.
Ensuring Regulatory Compliance.
The first Swiss-made AI platform purpose-built to transform R&D for the Nutraceutical, Cosmetic and Medical Device sectors.
Reduce your time-to-market by up to 70% with integrated in-silico research and clinical surveillance. HubMed™ is the digital scientific partner that turns overwhelming data into actionable evidence.
Overcoming the Limits of Traditional R&D
R&D teams in specialized life sciences face unprecedented bottlenecks.
HubMed™ solves the 'fragmentation gap' between initial discovery and final audit-readiness by moving beyond manual molecule ideation and distilling overwhelming volumes of scientific literature into actionable evidence.
The HubMed™ Ecosystem:
Bridging the Gap from Lab to Market
Adam™ | Accelerating Discovery
In-Silico Early Discovery & Molecule Screening.
Identify promising bioactive compounds with intelligent screening.
Optimize hits through advanced receptorial and toxicological safety profiling.
Transition from "predicting" to "creating" innovative molecular leads
10x faster identification of promising active ingredients
60–80% reduction in candidate screening costs
Medea™ | Ensuring Compliance
Clinical Evaluation, SOTA Analysis & Regulatory Literature Surveillance.
Automate Comparative Effectiveness Research (CER) and State of the Art (SOTA) analysis using the PICO framework.
Continuous literature monitoring and machine-reading of PubMed, Embase, and specialized scientific databases to eliminate gaps in evidence.
Generate audit-ready documentation for MDR and IVDR with unmatched precision.
Swiss Precision Meets AI Innovation
We don’t just provide tools, we provide a unified ecosystem designed for precision and trust.
Swiss-Made Reliability
Engineered with the highest standards of Swiss precision to safeguard your sensitive R&D data.
AI-Powered Insights
HubMed acts as an intelligent research assistant, distilling complex data so your experts can focus on high-value scientific decision-making.
End-to-End Integration
The only platform that ensures data continuity from the first preclinical molecule screening to the final clinical evaluation report
Maximum Security
A "secure vault" for your intellectual property, ensuring GDPR compliance and Swiss data privacy standards.
Specialized AI for Your Industry
Cosmetics
In-silico safety profiling and innovative skincare ingredient discovery — the sustainable alternative to traditional testing
Contract Research Organization (CRO)
Enhancing operational efficiency, profitability, and audit-readiness ('NB-ready' documentation) for large-scale research organizations.
Evidence-Based Results: Driving R&D Excellence
Used by leading R&D teams to navigate complex therapeutic avenues and regulatory landscapes.
0 Major Non-Conformities
100% audit-ready documentation for our pilot clients.
70% Reduction
in literature monitoring and document preparation time.
Zero-Gaps
in regulatory submissions through standardized PICO methodology.
Accelerated GTM
Bringing innovative ingredients to market faster than ever before.
Latest articles from our blog
Explore the latest research, insights, and technological trends driving the next generation of Nutraceuticals and Medical Devices. From in-silico molecule discovery to automated MDR compliance, stay informed with practical tips and expert analysis designed to accelerate your R&D lifecycle.
Frequently asked questions
Here are some common questions about our company.
HubMed utilizes a unified AI ecosystem to automate high-value scientific processes. By integrating In-silico compound discovery (Adam) with Clinical Evaluation (Medea), teams drastically reduce time spent on literature monitoring and documentation.
While HubMed is a powerful biotech brand, our platform is purpose-built for the Nutraceutical, Cosmetic, and Medical Device sectors, focusing on ingredient innovation and MDR/IVDR compliance.
Unlike standard tools, HubMed’s engine machine-reads thousands of scientific publications to distill actionable evidence. It utilizes the PICO framework to ensure every insight is structured, traceable, and ready for Notified Body audits.
Medea eliminates the risk of regulatory rejection by automating State of the Art (SOTA) analysis and systematic reviews. It maps evidence directly to GSPR requirements, ensuring full compliance and gap-free submissions.
As a Swiss-made platform, security is our cornerstone. All data is protected in a "vault" environment that meets the highest Swiss data privacy standards and GDPR.
HubMed automates the staged EUDAMED module requirements and manages the complex transition periods for legacy devices (up to 2027/2029) to ensure continuous market availability.
Ready to Revolutionize Your R&D Workflow?
Join the future of ingredient innovation and regulatory excellence.